Female Sexual Dysfunction: A Systematic Overview of Classification, Pathophysiology, Diagnosis and Treatment;Weibliche Sexuelle Funktionsstörungen: Klassifikation, Diagnostik und Therapie

Fortschritte der Neurologie Psychiatrie

Volumn 72, Issue 3, 2004, Pages 121-135

  Marthol, H ^a   Hilz, M J ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; APOMORPHINE; ARGININE; ESTROGEN; NEUROTRANSMITTER; NITRIC OXIDE; PHENTOLAMINE; PROSTAGLANDIN E1; SILDENAFIL; VASOACTIVE INTESTINAL POLYPEPTIDE; YOHIMBINE;

ADRENERGIC SYSTEM; AROUSAL; ATHEROSCLEROSIS; AVERSION; BLOOD FLOW; BURNING SENSATION; CENTRAL NERVOUS SYSTEM; CLITORIS; DIABETIC NEUROPATHY; DISEASE CLASSIFICATION; DISTRESS SYNDROME; DOPPLER ECHOGRAPHY; DRUG EFFICACY; EVOKED RESPONSE; FEMALE; FEMALE SEXUAL DYSFUNCTION; HIPPOCAMPUS; HORMONAL REGULATION; HORMONE SUBSTITUTION; HUMAN; HYPOTHALAMUS; LUBRICATION; ORGASM; ORGASM DISORDER; OXYGEN TENSION; PAIN; PATHOPHYSIOLOGY; PELVIS FLOOR; PERCEPTIVE THRESHOLD; PH MEASUREMENT; PHOTOELECTRIC PLETHYSMOGRAPHY; PUDENDAL NERVE; REVIEW; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SMOOTH MUSCLE RELAXATION; UTERUS; VAGINA; VIBRATION; WELLBEING;

ADULT; FEMALE; HUMANS; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

EID: 1642263882     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-818357     Document Type: Review

References (129)

1. World Health Organization. ICD-10: International Statistical Classification of Diseases and Related Health Problems. Geneva: World Health Organization, 1992
2. American Psychiatric Association. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington D. C.: American Psychiatric Press, 1994
3. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999; 281: 537-544
4. Tarcan T, Park K, Goldstein I, Malo G, Fassina A, Krane RJ, Azadzoi KM. Histomorphometric analysis of age-related structural changes in human clitoral cavernosal tissue. J Urol 1999; 161: 940-944
5. Berman JR, Adhikari SP, Goldstein I. Anatomy and physiology of female sexual function and dysfunction: classification, evaluation and treatment options. Eur Urol 2000; 38: 20-29
6. Berman JR, Goldstein I. Female sexual dysfunction. Urol Clin North Am 2001; 28: 405-416
7. Sjoberg I. The vagina. Morphological, functional and etiological aspects. Acta Obstet Gynecol Scand 1992; 71: 84-85
8. Weber AM, Walters MD, Schover LR, Mitchinson A. Vaginal anatomy and sexual function. Obstet Gynecol 1995; 86: 946-949
9. Moore KL. Clinically Oriented Anatomy, ed 3. Baltimore: Williams & Wilkins, 1992
10. Netter FH. The Ciba Collection of Medical Illustrations, Volume I: Nervous System. Summit, New Jersey: Ciba Pharmaceutical Products, Inc., 1953
11. Wagner G. Aspects of genital physiology and pathology. Semin Neurol 1992; 12: 87-97
12. Levin RJ. The mechanism of human female sexual arousal. Annu Rev Sex Res 1992; 3: 1-48
13. Schiavi RC, Segraves RT. The biology of sexual function. Psychiatr Clin North Am 1995; 18: 7-23
14. Levin RJ. The physiology of sexual function in women. Clin Obstet Gynaecol 1980; 7: 213-252
15. Levin RJ. VIP, vagina, clitoral and periurethral glans - an update on human female genital arousal. Exp Clin Endocrinol 1991; 98: 61-69
16. April EW. Anatomy. Baltimore: Williams & Wilkins, 1990
17. O'Connell HE, Hutson JM, Anderson CR, Plenter RJ. Anatomical relationship between urethra and clitoris. J Urol 1998; 159: 1892-1897
18. Masters EH, Johnson VE. Human Sexual Response. Boston: Little, Brown, 1966
19. Kaplan HS. The New Sex Therapy. London: Bailliere, Tindall, 1974
20. Basson R, Berman J, Burnett A, Derogatis L, Ferguson D, Fourcroy J, Goldstein I, Graziottin A, Heiman J, Laan E, Leiblum S, Padma-Nathan H, Rosen R, Segraves K, Segraves RT, Shabsigh R, Sipski M, Wagner G, Whipple B. Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol 2000; 163: 888-893
21. Carlson KJ. Outcomes of hysterectomy. Clin Obstet Gynecol 1997; 40: 939-946
22. Brackett NL, Bloch WE, Abae M. Neurological Anatomy and Physiology of Sexual Function. In: Singer C, Weiner WJ (Hrsg.). Sexual Dysfunction: A Neuro-Medical Approach. Armonk, NY: Futura Publishing Company, Inc., 1994: 1-43
23. Park K, Goldstein I, Andry C, Siroky MB, Krane RJ, Azadzoi KM. Vasculogenic female sexual dysfunction: the hemodynamic basis for vaginal engorgement insufficiency and clitoral erectile insufficiency. Int J Impot Res 1997; 9: 27-37
24. Park K, Moreland RB, Goldstein I, Atala A, Traish A. Sildenafil inhibits phosphodiesterase type 5 in human clitoral corpus cavernosum smooth muscle. Biochem Biophys Res Commun 1998; 249: 612-617
25. Graber B, Kline-Graber G. Female orgasm: role of pubococcygeus muscle. J Clin Psychiatry 1979; 40: 348-351
26. Martinez-Arizala A, Brackett NL. Sexual Dysfunction in Spinal Injury. In: Singer C, Weiner WJ (Hrsg.). Sexual Dysfunction: A Neuro-Medical Approach. Armonk, NY: Futura Publishing Company, Inc., 1994: 135-153
27. Fox CA, Fox B. Blood pressure and respiratory patterns during human coitus. J Reprod Fert 1969; 19: 405-415
28. Wiedeking C, Ziegler MG, Lake CR. Plasma noradrenaline and dopamine-beta-hydroxylase during human sexual activity. J Psychiatr Res 1979; 15: 139-145
29. Meston CM. Sympathetic nervous system activity and female sexual arousal. Am J Cardiol 2000; 86: 30F-34F
30. Tuiten A, Honk J van, Koppeschaar H, Bernaards C, Thijssen J, Verbaten R. Time course of effects of testosterone administration on sexual arousal in women. Arch Gen Psychiatry 2000; 57: 149-153; discussion 155-156
31. Hoyle CH, Stones RW, Robson T, Whitley K, Burnstock G. Innervation of vasculature and microvasculature of the human vagina by NOS and neuropeptide-containing nerves. J Anat 1996; 188: 633-644
32. Hsueh WA. Sexual dysfunction with aging and systemic hypertension. Am J Cardiol 1998; 61: 18H-23H
33. Thomas G, Ramwell PW. Nitric Oxide, Donors & Inhibitors. In: Katzung BG (Hrsg.). Basic & Clinical Pharmacology. Stamford, Connecticut: Appleton & Lange, 1998: 319-324
34. Traish A, Moreland RB, Huang YH, Kim NN, Berman J, Goldstein I. Development of human and rabbit vaginal smooth muscle cell cultures: effects of vasoactive agents on intracellular levels of cyclic nucleotides. Mol Cell Biol Res Commun 1999; 2: 131-137
35. Reid IA. Vasoactive Peptides. In: Katzung BG (Hrsg.). Basic & Clinical Pharmacology. Stamford, Connecticut: Appleton & Lange, 1998: 287-303
36. Stenchever MA, Drogenmueller W, Herbst AL, Mishell Jr DR. Comprehensive Gynecology. St. Louis: Mosby, Inc., 2001
37. Berman JR, Berman L, Goldstein I. Female sexual dysfunction: incidence, pathophysiology, evaluation, and treatment options. Urology 1999; 54: 385-391
38. Sarrell PM. Ovarian hormones and vaginal blood flow: Using laser Doppler velocimetry to measure effects in a clinical trial of postmenopausal women. Int J Impot Res 1998; 10: S91-S93
39. Sarrell PM. Sexuality and menopause. Obstet Gynecol 1990; 75: 26s
40. Arlt W, Callies F, Allolio B. DHEA replacement in women with adrenal insufficiency - pharmacokinetics, bioconversion and clinical effects on well-being, sexuality and cognition. Endocr Res 2000; 26: 505-511
41. Traish AM, Kim N, Min K, Munarriz R, Goldstein I. Role of androgens in female genital sexual arousal: receptor expression, structure, and function. Fertil Steril 2002; 77: 11-18
42. Kaplan HS, Owett T. The female androgen deficiency syndrome. J Sex Marital Ther 1993; 19: 3-24
43. Davis S. Testosterone and sexual desire in women. J Sex Education Ther 2000; 25: 25-32
44. Sourla A, Flamand M, Belanger A, Labrie F. Effect of dehydroepian-drosterone on vaginal and uterine histomorphology in the rat. J Steroid Biochem Mol Biol 1998; 66: 137-149
45. Kennedy TG, Armstrong DT. Induction of vaginal mucification in rats with testosterone and 17beta-hydroxy-5alpha-androstan-3-one. Steroids 1976; 27: 423-430
46. Kennedy TG. Vaginal mucification in the ovariectomized rat in response to 5alpha-pregnane-3,20-dione, testosterone and 5alpha-androstan-17beta-ol-3-one: test for progestogenic activity. J Endocrinol 1974; 61: 293-300
47. Kennedy TG. Proceedings: Vaginal mucification in the ovariectomized rat in response to 5alpha-pregnan-3,20-dione, testosterone and 5alpha-androstan-17beta-ol-3-one: test for progestagenic activity. J Reprod Fertil 1974; 36: 488-489
48. Sherwin BB, Gelfand MM. Differential symptom response to Parenteral estrogen and/or androgen administration in the surgical menopause. Am J Obstet Gynecol 1985; 151: 153-160
49. Sherwin BB, Gelfand MM. The role of androgen in the maintenance of sexual functioning in oophorectomized women. Psychosom Med 1987; 49: 397-409
50. Davis SR. Androgens and female sexuality. J Gend Specif Med 2000; 3: 36-40
51. Heiman JR. Female Sexual Dysfunction: Definitions, History-Taking Techniques, and Work-Up. In: Singer C, Weiner WJ (Hrsg.). Sexual Dysfunction: A Neuro-Medical Approach. Armonk, NY: Futura Publishing Company, Inc., 1994: 61-75
52. Moynihan R. The making of a disease: female sexual dysfunction. BMJ 2003; 326: 45-47
53. Bancroft J. The medicalization of female sexual dysfunction: the need for caution. Arch Sex Behav 2002; 31: 451-455
54. Goldstein I, Berman JR. Vasculogenic female sexual dysfunction: vaginal engorgement and clitoral erectile insufficiency syndromes. Int J Impot Res 1998; 10: S84-S90; discussion S98-S101
55. Myers LS, Morokoff PJ. Physiological and subjective sexual arousal in pre- and postmenopausal women and postmenopausal women taking replacement therapy. Psychophysiology 1986; 23: 283-292
56. Hilz MJ, Hecht M, Kölsch C. Erektile Dysfunktion. Akt Neurol 2000; 27: 1-12
57. Zemel P. Sexual dysfunction in the diabetic patient with hypertension. Am J Cardiol 1988; 61: 27H-33H
58. Kolodny RC. Sexual dysfunction in diabetic females. Diabetes 1971; 20: 557-559
59. Hatzichristou DG, Seftel AD, deTejada IS. Sexual Dysfunction in Diabetes and Other Autonomic Neuropathies. In: Singer C, Weiner WJ (Hrsg.). Sexual Dysfunction: A Neuro-Medical Approach. Armonk, NY: Futura Publishing Company, Inc., 1994: 167-198
60. Jensen SB. Diabetic sexual dysfunction: a comparative study of 160 insulin treated diabetic men and women and an age-matched control group. Arch Sex Behav 1981; 10: 493-504
61. Torrens MJ. Neurologic and neurosurgical disorders associated with impotence. In: Krane RJ, Siroky MB, Goldstein I (Hrsg.). Male Sexual Dysfunction. Boston, MA: Little, Brown, 1983
62. Brown RG, Jahanshahi M, Quinn N, Marsden CD. Sexual function in patients with Parkinson's disease and their partners. J Neurol Neurosurg Psychiatry 1990; 53: 480-486
63. Koller WC, Vetere-Overfield B, Williamson A, Busenbark K, Nash J, Parrish D. Sexual dysfunction in Parkinson's disease. Clin Neuropharmacol 1990; 13: 461-463
64. Rinne UK, Sonninen V, Siirtola T. L-Dopa treatment in Parkinson's Disease. Eur Neurol 1970; 4: 348-369
65. Singer C, Weiner WJ. Sexual Dysfunction in Parkinson's Disease. In: Singer C, Weiner WJ (Hrsg.). Sexual Dysfunction: A Neuro-Medical Approach. Armonk, NY: Futura Publishing Company, Inc., 1994: 119-134
66. Dewis ME, Thornton NG. Sexual dysfunction in multiple sclerosis. J Neurosci Nurs 1989; 21: 175-179
67. Miller AE. Sexual Dysfunction in Multiple Sclerosis. In: Singer C, Weiner WJ (Hrsg.). Sexual Dysfunction: A Neuro-Medical Approach. Armonk, NY: Futura Publishing Company, Inc., 1994: 155-165
68. Valleroy ML, Kraft GH. Sexual dysfunction in multiple sclerosis. Arch Phys Med Rehabil 1984; 65: 125-128
69. Minderhoud JM, Leemhuis JG, Kremer J, Laban E, Smits PM. Sexual disturbances arising from multiple sclerosis. Acta Neurol Scand 1984; 70: 299-306
70. Lilius HG, Valtonen EJ, Wikstrom J. Sexual problems in patients suffering from multiple sclerosis. J Chronic Dis 1976; 29: 643-647
71. McGuire EJ. Sexuality and urology. In: Leyson JFJ (Hrsg.). Sexual Rehabilitation of the Spinal-Cord-Injured Patient. Clifton, NJ: Humana Press, 1991: 55-67
72. Griffith ER, Trieschmann RB. Sexual functioning in women with spinal cord injury. Arch Phys Med Rehabil 1975; 56: 18-21
73. Berard EJ. The sexuality of spinal cord injured women: physiology and pathophysiology. A review. Paraplegia 1989; 27: 99-112
74. Nygaard I, Bartscht KD, Cole S. Sexuality and reproduction in spinal cord injured women. Obstet Gynecol Surv 1990; 45: 727-732
75. Verduyn WH. Spinal-cord-injuried women. In: Leyson JFJ (Hrsg.). Sexual Rehabilitation of the Spinal-Cord-Injuried Patient. Clifton, NJ: Humana Press, 1991: 197-206
76. Sipski ML, Alexander CJ, Rosen RC. Orgasm in women with spinal cord injuries: a laboratory-based assessment. Arch Phys Med Rehabil 1995; 76: 1097-1102
77. Cummings JL, Miller BL. Disorders of Sexual Behavior in Neurological Disease. In: Singer C, Weiner WJ (Hrsg.). Sexual Dysfunction: A Neuro-Medical Approach. Armonk, NY: Futura Publishing Company, Inc., 1994: 199-218
78. Kalliomaki JL, Markkanen TK, Mustonen VA. Sexual behavior after cerebral vascular accident. Fertil Steril 1961; 12: 156-159
79. Coslett HB, Heilman KM. Male sexual function. Impairment after right hemisphere stroke. Arch Neurol 1986; 43: 1036-1039
80. Shukla GD, Srivastava ON, Katiyar BC. Sexual disturbances in temporal lobe epilepsy: a controlled study. Br J Psychiatry 1979; 134: 288-292
81. Cogen PH, Antunes JL, Correll JW. Reproductive function in temporal lobe epilepsy: the effect of temporal lobectomy. Surg Neurol 1979; 12: 243-246
82. Johnson J. Sexual impotence and the limbic system. Br J Psychiatry 1965; 111: 300-303
83. Shapira J, Cummings JL. Alzheimer's disease: changes in sexual behavior. Med Aspects Human Sex 1989; 23: 32-35
84. McCoy NL, Davidson JM. A longitudinal study of the effects of menopause on sexuality. Maturitas 1985; 7: 203-210
85. Sarrel PM, Bajulaiya P. A survey of menopause related symptoms in Nigeria. In: 5th International Congress on Menopause. Orlando, FL, 1984
86. Wilsnack SC. Drinking, sexuality and sexual dysfunction in women. In: Wilsnack SC, Beckman LJ (Hrsg.). Alcohol Problems in Women: Antecedents, Consequences, and Interventions. New York, NY: Guilford Press, 1984: 349-368
87. Condra M, Morales A, Owen JA, Surridge DH, Fenemore J. Prevalence and significance of tobacco smoking in impotence. Urology 1986; 27: 495-498
88. Brown GW. Epidemiological studies of depression: definition and case finding. In: Becker J, Kleinman A (Hrsg.). Psychosocial Aspects of Depression. Hillsdale, NJ: Lawrence Erlbaum, 1991: 1-38
89. McCabe MP, Delaney SM. An evaluation of therapeutic programs for the treatment of secondary inorgasmia in women. Arch Sex Behav 1992; 21: 69-89
90. Rosen RC, Beck JG. Patterns of sexual arousal: psychophysiological processes and clinical applications. New York: Guilford Press, 1988
91. Laan E, Everaerd W. Physiological measures of vaginal vasocongestion. Int J Impot Res 1998; 10: S107-S110; discussion S124-S125
92. Meuwissen I, Over R. Multidimensionality of the content of female sexual fantasy. Behav Res Ther 1991; 29: 179-189
93. Rosen RC. Assessment of female sexual dysfunction: review of validated methods. Fertil Steril 2002; 77: 89-93
94. Sommer F, Caspers HP, Esders K, Klotz T, Engelmann U. Measurement of vaginal and minor labial oxygen tension for the evaluation of female sexual function. J Urol 2001; 165: 1181-1184
95. Berman J, Berman L. For Women Only: A Revolutionary Guide to Overcoming Sexual Dysfunction and Reclaiming Your Sex Life. New York: Henry Holt and Company, Inc., 2001
96. Yang CC, Bowen JR, Kraft GH, Uchio EM, Kromm BG. Cortical evoked potentials of the dorsal nerve of the clitoris and female sexual dysfunction in multiple sclerosis. J Urol 2000; 164: 2010-2013
97. Yilmaz U, Soylu A, Ozcan C, Caliskan O. Clitoral electromyography. J Urol 2002; 167: 616-620
98. Fabra M, Frieling A, Porst H, Schneider E. Single potential analysis of corpus cavernosum electromyography for the assessment of erectile dysfunction: provocation, reproducibility and age dependence - findings in 36 healthy volunteers and 324 patients. J Urol 1997; 158: 444-450
99. Vardi Y, Gruenwald I, Sprecher E, Gertman I, Yartnitsky D. Normative values for female genital sensation. Urology 2000; 56: 1035-1040
100. Romanzi LJ, Groutz A, Feroz F, Blaivas JG. Evaluation of female external genitalia sensitivity to pressure/touch: a preliminary prospective study using Semmes-Weinstein monofilaments. Urology 2001; 57: 1145-1150
101. Semmes J, Weinstein S, Ghent L, Teuber HL. Somatosensory Changes After Penetrating Brain Wounds in Man. Cambridge: Harvard University Press, 1960
102. Weinstein S. Tactile sensitivity of the phalanges. Percept Mot Skills 1962; 14: 351-354
103. Lightner DJ. Female sexual dysfunction. Mayo Clin Proc 2002; 77: 698-702
104. Hirshfield RM. Management of sexual side effects of antidepressant therapy. J Clin Psychiatry 1999; 60: 27-30
105. Hilz MJ. Erektile Dysfunktion. MMW Fortschr Med 2002; 144: 41-44
106. Porst H. Manual der Impotenz. Erektions-, Ejakulations- und Hormonstörungen, Peniserkrankungen, weibliche Sexualstörungen. Bremen: UniMed, 2000
107. Dennerstein L, Burrows GD, Wood C, Hyman G. Hormones and sexuality: effect of estrogen and progestogen. Obstet Gynecol 1980; 56: 316-322
108. McClure RD, Marshall L. Endocrinologic Sexual Dysfunction. In: Singer C, Weiner WJ (Hrsg.). Sexual Dysfunction: A Neuro-Medical Approach. Armonk, NY: Futura Publishing Company, Inc., 1994: 245-273
109. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-333
110. Sherwin BB, Gelfand MM, Brender W. Androgen enhances sexual motivation in females: a prospective, crossover study of sex steroid administration in the surgical menopause. Psychosom Med 1985; 47: 339-351
111. Shifren JL, Braunstein GD, Simon JA, Casson PR, Buster JE, Redmond GP, Burki RE, Ginsburg ES, Rosen RC, Leiblum SR, Caramelli KE, Mazer NA. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000; 343: 682-688
112. Couzinet B, Meduri G, Lecce MG, Young J, Brailly S, Loosfelt H, Milgrom E, Schaison G. The postmenopausal ovary is not a major androgen-producing gland. J Clin Endocrinol Metab 2001; 86: 5060-5066
113. Labrie F, Belanger A, Cusan L, Gomez JL, Candas B. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab 1997; 82: 2396-2402
114. Longcope C, Franz C, Morello C, Baker R, Johnston Jr CC. Steroid and gonadotropin levels in women during the peri-menopausal years. Maturitas 1986; 8: 189-196
115. Zumoff B, Strain GW, Miller LK, Rosner W. Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women. J Clin Endocrinol Metab 1995; 80: 1429-1430
116. Spark RF. Dehydroepiandrosterone: a springboard hormone for female sexuality. Fertil Steril 2002; 77: 19-25
117. Allolio B, Arlt W. DHEA treatment: myth or reality? Trends Endocrinol Metab 2002; 13: 288-294
118. Arlt W, Callies F, Vlijmen JC van, Koehler I, Reincke M, Bidlingmaier M, Huebler D, Oettel M, Ernst M, Schulte HM, Allolio B. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 1999; 341: 1013-1020
119. Lovas K, Gebre-Medhin G, Trovik TS, Fougner KJ, Uhlving S, Nedrebo BG, Myking OL, Kampe O, Husebye ES. Replacement of dehydroepiandrosterone in adrenal failure: no benefit for subjective health status and sexuality in a 9-month, randomized, parallel group clinical trial. J Clin Endocrinol Metab 2003; 88: 1112-1118
120. Caruso S, Intelisano G, Lupo L, Agnello C. Premenopausal women affected by sexual arousal disorder treated with sildenafil: a double-blind, cross-over, placebo-controlled study. BJOG 2001; 108: 623-628
121. Shen WW, Urosevich Z, Clayton DO. Sildenafil in the treatment of female sexual dysfunction induced by selective serotonin reuptake inhibitors. J Reprod Med 1999; 44: 535-542
122. Berman JR, Berman LA, Lin H, Flaherty E, Lahey N, Goldstein I, Cantey-Kiser J. Effect of sildenafil on subjective and physiologic parameters of the female sexual response in women with sexual arousal disorder. J Sex Marital Ther 2001; 27: 411-420
123. Sipski ML, Behnegar A. Neurogenic female sexual dysfunction: a review. Clin Auton Res 2001; 11: 279-283
124. Rosen RC, Phillips NA, Gendrano NC 3rd, Ferguson DM. Oral phentolamine and female sexual arousal disorder: a pilot study. J Sex Marital Ther 1999; 25: 137-144
125. Meston CM, Gorzalka BB, Wright JM. Inhibition of subjective and physiological sexual arousal in women by clonidine. Psychosom Med 1997; 59: 399-407
126. Meston CM, Heiman JR. Ephedrine-activated physiological sexual arousal in women. Arch Gen Psychiatry 1998; 55: 652-656
127. Meston CM, Gorzalka BB. Differential effects of sympathetic activation on sexual arousal in sexually dysfunctional and functional women. J Abnorm Psychol 1996; 105: 582-591
128. Padma-Nathan H, Giuliano F. Oral drug therapy for erectile dysfunction. Urol Clin North Am 2001; 28: 321-334
129. Dula E, Bukofzer S, Perdok R, George M Apomorphine S L Study Group. Double-blind, crossover comparison of 3 mg apomorphine SL with placebo and with 4 mg apomorphine SL in male erectile dysfunction. Eur Urol 2001; 39: 558-563; discussion 564